Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham et al.|Journal of Clinical Investigation|2020Cited by 863
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19Max R. O’Donnell, W. Ian Lipkin, Beatriz Grinsztejn et al.|Journal of Clinical Investigation|2021Cited by 172
Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusionRichard O. Francis, Eldad A. Hod, Sarah Gehrke et al.|Journal of Clinical Investigation|2020Cited by 116
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent PlasmaLise J Estcourt, Aaron A.R. Tobian, Claudia S. Cohn et al.|Annals of Internal Medicine|2022Cited by 71
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W. Senefeld, Janis E. Blair, Patrick W. Johnson et al.|PLoS Medicine|2021Cited by 65